Your Article Summary
See Latest ArticlesShort and long-term advantages of transhiatal and transthoracic oesophageal cancer resection
European Journal of Surgical Oncology, 06/30/09
Omloo JMT et al. - In a review of short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection, this overview describes short- and long-term advantages of these 2 strategies.
Methods- 2 major surgical strategies to improve survival rates after oesophagectomy for oesophageal cancer have emerged during the past decades; (limited) transhiatal oesophagectomy and (extended) transthoracic oesophagectomy with 2-field lymphadenectomy.
- In the short term, transhiatal oesophagectomy is accompanied by less morbidity.
- In the long term, this strategy is only preferable for pts with tumours located at the gastro-oesophageal junction, without involved lymph nodes in the proximal compartment of the chest.
- For pts with tumours located in the oesophagus, the transthoracic route with extended lymphadenectomy is probably preferred, because of improved long-term survival.
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer
Journal of Clinical Oncology, 11/02/09
Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer
Journal of Clinical Oncology, 11/03/09
Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study
British Journal of Cancer, 11/18/09